Validation of the electronic prescription as a method for measuring treatment adherence in hypertension

Patient Education and Counseling

Volumn 101, Issue 9, 2018, Pages 1654-1660

  Márquez Contreras, Emilio ^a   López García Ramos, Lourdes de ^b   Martell Claros, Nieves ^c   Gil Guillen, Vicente F ^d   Márquez Rivero, Sara ^a   Pérez López, Elena ^a   Garrido Lopez, Maria Angeles ^a   Farauste, Celia ^a   López Pineda, Adriana ^d   Casado Martinez, José Joaquin ^a   Orozco Beltran, Domingo ^d   Quesada, Jose A ^d   Carratalá Munuera, Concepción ^d  

^a La Orden Clinical Management Unit   (Spain)

^b Adoratrices Clinical Management Unit   (Spain)

^c HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^d MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

Author keywords

Health promotion; Hypertension; Medication adherence; Patient compliance; Primary health care

Indexed keywords

ANTIHYPERTENSIVE AGENT; PRESCRIPTION DRUG;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; CONTROLLED STUDY; ELECTRONIC PRESCRIBING; FEMALE; GOLD STANDARD; HEALTH CARE FACILITY; HUMAN; HYPERTENSION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; MIDDLE AGED; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY; AGED; PSYCHOLOGY; REPRODUCIBILITY; SPAIN; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; ELECTRONIC PRESCRIBING; FEMALE; HUMANS; HYPERTENSION; LONGITUDINAL STUDIES; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PRESCRIPTION DRUGS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SPAIN;

EID: 85046776815     PISSN: 07383991     EISSN: 18735134     Source Type: Journal    
DOI: 10.1016/j.pec.2018.04.009     Document Type: Article

References (36)

1. ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur. Heart J. 34 (2013), 2159–2219.
2. MacMahon, S., Neal, B., Rodgers, A., Hypertension- time to move on. Lancet 365 (2005), 1108–1109.
3. Noncommunicable Diseases: A Major Health Challenge of the 21st Century World Health Statistics. 2012, World Health Organization, 35–36.
4. Rodríguez-Artalejo, F., Banegas, Banegas jr., Cardiovascular epidemiology and prevention. J. Epidemiol. Community Health 58 (2004), 116–119.
5. Gil-Guillén, V., Orozco-Beltrán, D., Pérez, R.P., et al. Clinical inertia in diagnosis and treatment of hypertension in primary care: quantification and associated factors. Blood Press. 19 (2010), 3–10.
6. Sharma, A.M., Wittchen, H.U., Kirch, W., et al. HYDRA Study Group: high prevalence and poor control of hypertension in primary care: cross-sectional study. J. Hypertens. 22 (2004), 479–486.
7. Kim, S., Shin, D.W., Yun, J.M., et al. Medication adherence and the risk of cardiovascular mortality and hospitalization among patients with newly prescribed antihypertensive medications. Hypertension 67 (2016), 506–512.
8. Sabaté E., Adherence to Long-term Therapies: Evidence for Action. 2003, World Health Organization, Geneva, Switzerland.
9. Lam, W.Y., Fresco, P., Medication adherence measures: an overview. BioMed. Res. Int., 2015, 2015, 217047.
10. Conthe Márquez, P., Contreras, E., Aliaga Pérez, A., et al. Treatment compliance in chronic illness: current situation and future perspectives. Rev. Clin. Esp. 214 (2014), 336–344.
11. Farmer, K.C., Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin. Ther. 21 (1999), 1074–1090.
12. Vermeire, E., Hearnshaw, H., Van Royen, P., Denekens, J., Patient adherence to treatment: three decades of research: a comprehensive review. J. Clin. Pharm. Ther. 26 (2001), 331–342.
13. DesRoches, C.M., Agarwal, R., Angst, C.M., Fischer, M.A., Differences between integrated and stand-alone E-prescribing systems have implications for future use. Health Aff. 29 (2010), 2268–2277.
14. Porterfield, A., Engelbert, K., Coustasse, A., Electronic prescribing improving the efficiency and accuracy of prescribing in the ambulatory care setting. Perspect. Health Inf. Manag., 11, 2014 (1g).
15. Brooks, P., Sonnenschein, C., E-prescribing: where health information and patient care intersect. J. Healthc. Inf. Manage. 24 (2010), 53–59.
16. eHealth Initiative and Center for Improving Medication Management A Clinician's Guide to Electronic Prescribing. 2008 https://ehi-rails-app.s3.amazonaws.com/uploads/article/file/449/2011-04-21_eHI_Clinicians-Guide-to-ePrescribing–2011_Update.pdf, (Accessed 10 November 2016).
17. Hansen, R.A., Kim, M.M., Song, L., Tu, W., Wu, J., Murray, M.D., Comparison of methods to assess medication adherence and classify nonadherence. Ann. Pharmacother. 43 (2009), 413–422.
18. Suárez-Varela Ubeda, J., Beltrán Calvo, C., Molina López, T., Navarro Marín, P., Computer-aided prescribing: from utopia to reality. Aten. Primaria 35 (2005), 451–456.
19. Conthe, P., Márquez Contreras, E., Aliaga Pérez, A., Barragán García, B., Fernández de Cano Martín, M.N., González Jurado, M., Ollero Baturone, M., Pinto, J.L., Treatment compliance in chronic illness: current situation and future perspectives. Rev. Clin. Esp. 214 (2014), 336–344.
20. 2007 guidelines for the management of arterial hipertension of the european society of hipertensión (ESH) and the european society of cardiology (ESC). Eur. Heart J. 9 (2007), C3–C74.
21. Puras, A., Cumplimiento del tratamiento farmacológico y grado de control en la hipertensión: estudio epidemiológico. ¿Quién cumple menos: el paciente o el médico? [Compliance with pharmacological treatment and degree of control in hypertension: epidemiological study. Who meets less: the patient or the doctor?]. Med. Clin. (Barc). 116 (2001), 101–104.
22. Márquez-Contreras, E., Martín de Pablos, J.L., Gil-Guillén, V., Martell-Claros, N., Motero Carrasco, J., Casado-Martínez, J.J., La inercia clínica profesional y el incumplimiento farmacológico: ¿cómo influyen en el control de la hipertensión arterial? Estudio CUMAMPA. [Professional clinical inertia and pharmacological noncompliance: how do they influence the control of arterial hypertension? CUMAMPA Study]. Hipertensión (Madr) 25 (2008), 187–193.
23. Márquez-Contreras, E., de la Figuera-Von Wichmann, M., Franch-Nadal, J., et al. Do patients with high vascular risk take antihypertensive medication correctly? Cumple-MEMS study. Rev. Esp. Cardiol. 65 (2012), 544–550.
24. Choudhry, N.K., Fischer, M.A., Avorn, J., et al. The implications of therapeutic complexity on adherence to cardiovascular medications. Arch. Intern. Med. 171 (2011), 814–822.
25. Alvarez-Sala, L.A., Suárez, C., Mantilla, T., et al. Estudio Prevencat: control del riesgo cardiovascular en atención primaria [Prevencat study: control of cardiovascular risk in primary care]. Med. Clin. (Barc). 124 (2005), 406–410.
26. Llisterri Caro, J.L., Rodríguez Roca, G.C., Alonso Moreno, F.J., et al. Blood pressure control in hypertensive Spanish population attended in primary care setting. The PRESCAP 2010 study. Med. Clin. (Barc). 139 (2012), 653–661.
27. Divisón, J.A., de Rivas, B., Márquez-Contreras, E., Sobreviela, E., Luque, M., investigadores del Estudio HICAP. Clinical characteristics and management of hypertense patients diagnosed of heart failure in primary health care in Spain. HICAP Study. Rev. Clin. Esp. 208 (2008), 124–129.
28. Puig-Junoy, J., Rodríguez-Feijoó S., Lopez-Valcarcel, B.G., Paying for formerly free medicines in Spain after 1 year of co-payment: changes in the number of dispensed prescriptions. Appl. Health Econ. Health Policy 12 (2014), 279–287.
29. Antoñanzas Villar, F., Rodríguez-Ibeas, R., Juárez-Castelló C.A., Lorente Antoñanzas, M.R., Impact of the Royal Decree-Law 16/2012 on the number of prescriptions and pharmaceutical expenditures. Rev. Esp. Salud. Publica. 88 (2014), 233–249.
30. Sinnott, S.J., Normand, C., Byrne, S., Woods, N., Whelton, H., Copayments for prescription medicines on a public health insurance scheme in Ireland. Pharmacoepidemiol. Drug Saf. 25:June (2016), 695–704.
31. Sinnot, S.J., Buckley, C., O'Riordan, D., Bradley, C., Whelton, H., The effect of copayments for prescription on adherente to prescription medicines in publicly insured populations; a systematic review and meta-analysis. PLoS One, 8, 2013, e64914.
32. Haynes, R.B., Taylor, D.W., Snow, J.C., Sackett, D.L., Annotated and indexed bibliography on compliance with therapeutic and preventive regimens. Haynes, R.B., Taylor, D.C., Sackett, D.L., (eds.) Compliance in Health Care, 1979, Johns Hopkins University Press, Baltimore, 337–474.
33. Vrijens, B., De Geest, S., Hughes, D.A., et al. ABC Project Team: a new taxonomy for describing and defining adherence to medications. Br. J. Clin. Pharmacol. 73 (2012), 691–705.
34. R.B. Haynes, E. Ackloo, N. Sahota, H.P. McDonald, X. Yao, Intervenciones para mejorar la adherencia a la medicación (Revisión Cochrane traducida). En: La Biblioteca Cochrane Plus, 2007. Oxford : Update Software Ltd. Traducida de The Cochrane Library. Ltd Issue 4 Chichester, UK: John Wile & Sons, Ltd UK: John Wile & Sons, 2007.
35. Vrijens, B., Vincze, G., Kristanto, P., Urquhart, J., Burnier, M., Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories. Br. Med. J. 336 (2008), 1114–1117.
36. Yang, W., Zilov, A., Soewondo, P., Bech, O.M., Sekkal, F., Home, P.D., Observational studies: going beyond the boundaries of randomized controlled trials. Diabetes Res. Clin. Pract. 88:Suppl. 1 (2010), S3–9.